收藏本站
我的資料
我的訂單
  購物車 (0)  
親,您的購物車空空的喲~
去購物車結算
   
查看手機網站
其他賬號登錄: 注冊 登錄
150-21460884
產品分類
Hydroxysafflor yellow A 
Hydroxysafflor yellow A
收藏
|
|
英文名稱 : Hydroxysafflor yellow A
貨號 : EY-01Y19581
CAS : 78281-02-4
含量 : >98.00%
規格 : 20mg
品牌 : 上海一研
價格 :
0.00
購買數量:
加入購物車  立即購買
產品保證
正品保證
快速發貨
產品詳情
產品評論(0)
銷售記錄(0)

產品屬性:


產品名稱

Hydroxysafflor yellow A

規格

20mg

貨號

EY-01Y19581

Cas No.: 78281-02-4

別名: Safflomin A

化學名: (6E)-2,5-dihydroxy-6-[(E)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-2,4-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohex-4-ene-1,3-dione

分子式: C27H32O16
GN10204.png
分子量: 612.53

溶解度: ≥ 61mg/mL in H2O, ≥ 61.3mg/mL in DMSO

儲存條件: 4°C, protect from light
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

Shipping Condition:Evaluation sample solution : ship with blue ice

All other available size: ship with RT , or blue ice upon request

產品描述:


Hydroxysafflor yellow A is a flavonoid derived and isolated from traditional Chinese medicine Carthamus tinctorius L., possesses anti-tumor activity. IC50 value:Target: in vitro: HYSA could inhibit LPS-induced VSMCs proliferation and migration, accompanied by the downregulated levels of several key pro-inflammatory cytokines, including TNF-α, IL-6, and IL-8. We further showed that HYSA inhibited LPS-induced upregulation of TLR-4 expression as well as the activation of Rac1/Akt pathway [1]. HSYA protected EC viability against LPS-induced injury (P<0.05). LPS-induced NF-κB p65 subunit DNA binding (P<0.01) and nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor -α (I-κB-α) phosphorylation was inhibited by HSYA. HSYA attenuated LPS triggered ICAM-1 and E-selectin mRNA levels elevation and phosphorylation of p38 MAPK or c-Jun N-terminal kinase MAPK [2]. HSYA inhibited the proliferation of 3T3-L1 preadipocytes and cell viability greatly decreased in a dose and time dependent manner. HSYA (1 mg/l) notably reduced the amount of intracellular lipid and triglyceride content in adipocytes by 21.3 % (2.13 ± 0.36 vs 2.71 ± 0.40, P < 0.01) and 22.6 % (1.33 ± 0.07 vs 1.72 ± 0.07, P < 0.01) on days 8 following the differentiation, respectively [3]. in vivo: HSYA treatment ameliorated serum biochemical indicators by reducing the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), hyaluronan (HA), laminin (LN), and type III precollagen (III-C) in rats [4].
特別提醒公司產品僅供科研使用


買家數量成交時間
正品保障

確保所有產品都是原裝正品

優質服務

優質服務,售后無憂

安全包裝

統一包裝,保障產品安全運輸

正規發票

機打發票,附箱送達

    配送方式            新手入門           售后服務           幫助中心           支付方式           關于我們
      包裝說明                會員服務                退款說明                服務協議               預付賬戶               聯系一研
      商品驗收                積分規則               退換款地址            投訴建議                發票制度
      配送查詢                購物流程                退換款流程            聯系客服               付款周期
      配送說明                會員體系                退換款原則            找回密碼               付款方式
手機掃一掃
訪問手機網站